Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Molecular mimicry wikipedia , lookup
Immune system wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Adaptive immune system wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
A Role for Immature Myeloid Cells in Immune Senescence Elena Y. Enioutina Diana Bareyanand Raymond A. Daynes Introduction Immune senescence • Causes and consequences of immune system aging in mammals • Compromised innate & adaptive immune responses • Oxidative stress & inflammatory cytokines Myeloid cells • Possessing immune suppressive activities • NO-dependent mechanism • Abnormal accumulation->cancers, persistent bacterial or viral infections, or after surgical trauma or thermal injury • Gr1+CD11b+ cells as myeloid-derived suppressor cells (MDSCs) MDSCs • suppress the proliferation of both CD4+ and CD8+ T cells • increased activities of arginine metabolizing enzymes, inducible NO synthase (iNOS), and/or arginase 1 (ARG-1) Review Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function Trends in Immunology Volume 32, Issue 1 January 2011, Pages 19-25 Introduction I. immune-compromising activities of Gr1+CD11b+ cells contribute to immune senescence? II. characterize the signaling defects responsible for their immune suppressive activities in aged hosts? The blood, secondary lymphoid organs, and BM of aged mice possess elevated numbers of myeloid cells bearing the Gr1+CD11b+ phenotype Gr1+CD11b+ cells residing in multiple lymphoid organs increased in aged mice BALB/c or DO11.10 18~22 mo 3 mo similar 5-fold ring shape : immature CD11b+Ly6CintLy6Gint -> CD31+(PECAM-1) CD11b+ 18~22 mo 3 mo CD11b+ BALB/c-Tg(DO11.10)10Loh/J • Mice carrying the MHC class II restricted rearranged T cell receptor transgene, Tg(DO11.10)10Dlo, react to ovalbumin (OVA) peptide antigen • Intraperitoneal administration of OVA to transgenic mice results in a rapid deletion of the immature CD4+ CD8+ TCRlo thymocytes with progression to mature thymocytes • increased accumulation of immature myeloid cells in multiple secondary lymphoid organs of aged mice -> orchestrate some of the immune dysfunctions associated with advanced age Stimulation of aged splenocytes with TLR4 ligand results in a significant increase in the percentage of Gr1+CD11b+ and CD4+ T cells producing proinflammatory cytokines Gr1+CD11b+ cells and CD4+ T cells in SPLs of aged mice produce proinflammatory cytokines Splenocytes : 1 × 106 cells/ml in the presence of 0, 10, or 100 ng/ml LPS A. Gr1+CD11b+ cells of BALB/c 3 mo 22 mo 6h 24 h 24 h 24 h Neutralizing 24 h B. CD4+ cells of DO11.10 48 h Sup.-> ELISA C. Splenocytes culture of BALB/c Gr1+CD11b+ cells from aged mice suppress CD4+ T cell responses, markedly increase iNOS or ARG-1 expression after activation, and produce elevated levels of proinflammatory cytokines Gr1+CD11b+ cells isolated from the SPLs of aged mice produce proinflammatory cytokines, increased activity of iNOS and ARG-1, suppressed CD4+ T cell proliferation OVA-specific CD4+ T cell proliferation B. Gr1+CD11b+ cells isolated from the SPLs Sup. 48 h 24 h 4d Gr1+CD11b+ cells from SPLs or BM of BALB/c : Splenocytes DO11.10 mice (3 mo) 2 × 106 cells/ml+100 μg/ml OVA ELISA Sup. 24 h 48 h C. Gr1+CD11b+ cells isolated from the SPLs Sup. 48 h Sup. 48 h Gr1+ myeloid cells residing in the lymphoid organs of aged mice negatively affect Ag-induced CD4+ T cell proliferation in vitro and the ability to mount T cell-dependent Ab responses in vivo Depletion of Gr1+ cells from the secondary lymphoid organs of aged mice normalizes their immune responsiveness A. Splenocytes DO11.10 mice (3 mo , 20 mo) 2 × 106 cells/ml+100 μg/ml OVA or Gr1 depleted splenocytes ( 20 mo ) Sup. In vivo Gr1 depletion of Gr1 by i.p. with anti-Gr1 mAb to aged DO11.10 mice on days −6, −3, and 0 Sup. Sup. s.c with 50 μl of vaccine containing 50 μg OVA in Alum T cell-dependent Ab responses Day 0 OVA-specific IgG Abs by ELISA Activated Gr1+CD11b+ cells from aged donors express decreased levels of phosphorylated Akt and fail to inactivate GSK3β effectively Review An Overview of Stress Response and Hypometabolic Strategies in Caenorhabditis elegans: Conserved and Contrasting Signals with the Mammalian System Int J Biol Sci 2010; 6:9-50 Purified Gr1+CD11b+cells from aged donors have a reduced ability to phosphorylate Akt and are incapable of effectively inactivating GSK3β Gr1+CD11b+ cells isolated from SPLs of BALB/c mice cocultured with LPS (10 ng/ml) for 30 and 60 min decreased decreased Total cellular proteins prep. ->Western blot SHIP1 is only expressed by hematopoietic cells and inhibits the downstream activation of Akt by enzymatically converting PI3K-induced PIP3 to PIP2 Total cellular proteins prep. ->Western blot The inhibition of GSK3β activity in Gr1+CD11b+ cells from aged mice ameliorates the proinflammatory condition and reduces inducible iNOS activity. Gr1+CD11b+ cells isolated from SPLs of BALB/c mice cocultured with LPS (10 ng/ml) + IFN-γ or IL-4 48 h -> ELISA reduced reduced reduced GSK3 inhibitor No change Treatment of activated CD4+ T cells isolated from aged donors with a specific GSK3 inhibitor enhances T cell proliferation, increases IL-2, and reduces IFN-γ production Splenocytes from DO11.10 mice were cultured 5 × 106cells/ml with OVA (100 μg/ml). 4 d -> ELISA 24 h -> ELISA CD4+ T cells isolated from SPLs of DO11.10 mice (5 × 106 cells/ml) -> anti-CD3ε (2 μg/ml) coated tissue culture plates -> Adding anti-CD28 Abs (2 μg/ml) Discussion • Multiple lymphoid organs of healthy aged mice harbor increased numbers of Gr1+CD11b+ cells • CD11b+Ly6CintLy6Gint -> suppressive activities of splenic Gr1+CD11b+ cells in aged mice ( Vitamin E -> enhancement ) • MDSC -> ↑iNOS (Salmonella infected) , ↑ ARG-1(transplantable tumor bearing) • Monocytes undergo a microenvironment-dependent polarization process • LPS + IFN-γ -> M1 macrophages -> iNOS • IL-4, IL-13, IL-10 -> M2 macrophages -> ARG-1 • immature Gr1+CD11b+ cells • LPS + IFN-γ -> iNOS • LPS + IL-4 -> ARG-1 • Many other substances (e.g., GM-CSF, G-CSF, PGs, S100A8/A9 proteins, IL-1β, IL-6, and IL-12) have been implicated in the expansion and activation of MDSCs • S100A8 and A9 are increased 1.5- to 2-fold in healthy aged mice • NO produced by splenic Gr1+ cells is responsible for suppressing CD4+ T cell activities with aging • Stimulated Gr1+CD11b+ cells from the SPLs of aged animals had a diminished capacity to activate Akt, resulting in a reduced ability to inactivate the downstream enzyme, GSK3β • SHIP-1 and PTEN are enyzmes that inhibit the Akt activation • Inhibition of GSK3 activity in stimulated Gr1+CD11b+ cells from aged mice • decreased the production of proinflammatory cytokines and iNOS activity • no effect on inducible ARG-1 activity • Increase T cell proliferation Discussion 5th IDO GVHD day 49 B6 vs IDO KO -> BALB.B B6 vs IDO KO -> B6 ) ) 1 1 b B6 vs IDO KO -> BALB.B 4th IDO GVHD day 70 b 3rd IDO GVHD day 94 0 0 10 20 30 40 50 60 70 80 90 D ay B 6 T C D B M + B 6 T c e lls - > B . B I D O K O T C D B M + B 6 T c e lls - > B . B 100 t n ( D i 1 t 6 % t G 3 9 n 1 r 6 i n C - 9 12 C D 1 1 b in t C h a n g e 15 12 9 6 i 12 15 in t 3 3 G 15 G r-1 1 Gr-1int CD11bint Change C h an g e C - in t r C D 11b Gr-1int CD11bint(%) t n in t i ( D % 1 G r-1 0 0 0 10 20 30 40 50 60 70 80 90 100 Day 0 10 20 30 40 50 60 70 80 90 D a y B6 TCD BM+ B6 T cells -> B.B B 6 T C D B M + B 6 T c e lls - > B 6 IDO KO TCD BM + B6 T cells -> B.B I D O K O T C D B M + B 6 T c e lls - > B 6 100 Discussion 5th IDO GVHD day 49 B6 vs IDO KO -> BALB.B B6 vs IDO KO -> B6 0 0 10 20 30 40 50 60 70 80 90 D ay B 6 T C D B M + B 6 T c e lls - > B . B I D O K O T C D B M + B 6 T c e lls - > B . B 100 h %1 g i D h 10 C D 1 1 b h ig h C h a n g e 25 1 10 15 t 15 20 in t 30 20 C - 20 25 G r-1 15 r 25 30 n 30 5 G Gr-1int CD11bhigh Change C h an g e 10 i h ig h 5 5 G C D 11b Gr-1int CD11bhigh (%) % 1 ( i h t C r in t i n 1 D g h G r-1 ( ) 1 ) 1 b B6 vs IDO KO -> BALB.B b 4th IDO GVHD day 70 3rd IDO GVHD day 94 0 0 10 20 30 40 50 60 70 80 90 100 Day 0 0 10 20 30 40 50 60 70 80 90 D a y B6 TCD BM+ B6 T cells -> B.B B 6 T C D B M + B 6 T c e lls - > B 6 IDO KO TCD BM + B6 T cells -> B.B I D O K O T C D B M + B 6 T c e lls - > B 6 100 Discussion 4th IDO GVHD day 70 3rd IDO GVHD day 94 Gr-1high CD11bhigh(%) Gr-1 high CD11b Change 100 90 80 70 60 50 40 30 20 10 0 0 10 20 30 40 50 60 70 80 90 100 Day B6 TCD BM+ B6 T cells -> B.B IDO KO TCD BM + B6 T cells -> B.B B6 vs IDO KO -> BALB.B B6 vs IDO KO -> B6 Gr-1high CD11bhigh Change Gr-1high CD11bhigh Change 100 90 80 70 60 50 40 30 20 10 0 Gr-1high CD11b high (%) high Gr-1high CD11bhigh (%) B6 vs IDO KO -> BALB.B 5th IDO GVHD day 49 0 10 20 30 40 50 60 70 80 90 100 Day 100 90 80 70 60 50 40 30 20 10 0 0 10 20 30 40 50 60 70 80 90 100 Day B6 TCD BM+ B6 T cells -> B.B B6 TCD BM+ B6 T cells -> B6 IDO KO TCD BM + B6 T cells -> B.B IDO KO TCD BM + B6 T cells -> B6